£442K
The London startup will scale its business-to-business product offering to meet rising demand from ethical consumers.
"This raise confirms that now is the time for businesses to transition and contribute to sustainable and ethical economies."
Funding Announcements
Filter
Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 2 November 2026.
Announcements
6,260
Total raised
£165B
disclosed amounts
This month
£9.0M
raised so far
£38.4M
London Stock Exchange Group and other major backers join Series B round to support international growth and technology development.
"The COVID-19 pandemic demonstrated the effectiveness of the public markets, with companies recapitalising quickly and efficiently. Our technology has allowed thousands of retail investors to participate on equal terms with institutional investors, unlocking a large and important source of liquidity and long-term share ownership for corporate issuers. The response from Boards and their advisers to our solution has been excellent: they recognise our digital solution for retail inclusion brings together both good governance and best execution."
£1.0M
Fortunis Capital backed the female-led mental wellbeing app to accelerate its growth and service expansion.
"We have huge growth plans – we are the only mental wellbeing app that really, really understands what women need when it comes to their mental wellbeing. In a space where the leading apps are all lead by men it’s time to shake this up."
£760K
Techstart Ventures led the round with backing from Active Capital and Ankur Nagpal.
"Online summits have been a tool for digital marketers to share knowledge, but it’s always been complicated and cost-prohibitive for most entrepreneurs,"
£1.0M
The Reading-based healthcare technology company secured the financing over five months to progress product development and clinical trials.
"Healthcare is one of the areas of biggest interest to our investor database. In the year of a global pandemic this is perhaps no surprise – but this business really did tick all the boxes for our investors. They have patent-protected IP with a product developed by a team with extensive medical experience. They also have a track record of high value medical and technology exits. We look forward to seeing the development of this business and its potential ability to improve the lives of millions of people."
